Financial Summary (All financials)
| In millions, except per share items | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 | Mar-31-15 | Mar-31-14 | Mar-31-13 | Mar-31-12 |
| Revenues | 2,903.3 | 3,140.3 | 2,886.9 | 2,660.8 | 2,819.1 | 2,741.8 | 2,612.7 | 0.0 |
| Revenue growth | -7.5% | 8.8% | 8.5% | -5.6% | 2.8% | 4.9% | | |
| Cost of goods sold | 1,398.0 | 1,503.0 | 1,374.3 | 1,172.6 | 1,208.2 | 0.0 | 0.0 | 0.0 |
| Gross profit | 1,505.2 | 1,637.3 | 1,512.6 | 1,488.2 | 1,610.9 | 2,741.8 | 2,612.7 | 0.0 |
| Gross margin | 51.8% | 52.1% | 52.4% | 55.9% | 57.1% | 100.0% | 100.0% | |
| Selling, general and administrative | 0.0 | 229.0 | 0.0 | 0.0 | 0.0 | 0.0 | 734.0 | 73.1 |
| Research and development | | | | | | | | |
| EBIT | 1,505.2 | 1,637.3 | 1,512.6 | 1,488.2 | 1,610.9 | 0.0 | 2,612.7 | 73.1 |
| EBIT margin | 51.8% | 52.1% | 52.4% | 55.9% | 57.1% | 0.0% | 100.0% | |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 20.6 | -102.5 | 84.2 | 7.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | | | | | |
| Net income | 0.0 | 285.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 9.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| |
| Diluted EPS | | | | | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | | | | | 116.2 | 122.2 | 133.3 | 143.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|